BCIS ACI 2020: CTO PCI Has No Prognostic Benefit - Is It a Waste of Time & Money?
Published: 07 February 2020
-
Views:
38 -
Likes:
7
-
Views:
38 -
Likes:
7
Overview
This video debate series filmed at the BCIS ACI meeting 2020, examines whether or not CTO PCI has any prognostic benefits. They examine the pros and cons for use and discuss if the advantages outweigh the cost.
Thanks to BCIS for providing this footage
More from this programme
Part 1
Introduction and Preliminary Poll
1 session | |
Introduction and Preliminary Poll | Watch now |
Part 2
Pro Argument
1 session | |
Pro Argument | Watch now |
Part 3
Contra Argument
1 session | |
Contra Argument | Watch now |
Part 4
Panel Discussion
1 session | |
Panel Discussion | Watch now |
Faculty Biographies
Mark Gunning
Interventional Consultant Cardiologist
Dr Mark Gunning is an Interventional Consultant Cardiologist at Royal Stoke University Hospital, Stoke-on-Trent, UK with a specific interest in complex coronary anatomy, coronary calcification and concommitant cardiac and renal disease.
Daniel J Blackman
Interventional Cardiologist
Dr Daniel Blackman has a national and international reputation in trans-catheter aortic valve implantation (TAVI), having trained specialists throughout the UK, Europe, USA and Japan in performing TAVI.
James Spratt
Consultant Interventional Cardiologist
Dr James Spratt is one of a small number of interventional cardiologists in the world who are pioneering techniques to unblock coronary arteries by Percutaneous Coronary Intervention (PCI).
Rosemary Swallow
Consultant Interventional Cardiologist
Dr Rosemary Swallow is a consultant interventional cardiologist at Royal Bournemouth Hospital, Bournemouth, UK.